#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholestatic pruritus Autoimmune demyelinating disease Progressive supranuclear palsy Myocarditis Herpes simplex Haemolytic uraemic syndrome Cervix carcinoma recurrent Deafness bilateral Necrotising enterocolitis neonatal Malignant melanoma Blastic plasmacytoid dendritic cell neoplasia Idiopathic inflammatory myopathy Lymphangiosarcoma HER2 mutant non-small cell lung cancer Scleroderma associated digital ulcer More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Synovial sarcoma – Diagnostics Myelodysplastic syndrome with excess blasts – Trials in Disease Haemophilia – Life with Disease Synovial sarcoma metastatic – Trials in Disease Haemophilia B without inhibitors – Life with Disease Haemolytic uraemic syndrome – Trials in Disease Niemann-Pick disease – Treatment Osteosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zilucoplan Sodium Inavolisib Defactinib Aldesleukin Alnuctamab Azelastine Hydrochloride Etanercept Secukinumab Tegafur VINBLASTINE Belinostat INF904 SOFOSBUVIR ANGIOTENSIN II Xaluritamig Imatinib Mesilate Midazolam Danicamtiv Vobramitamab Duocarmazine Bemnifosbuvir Hemisulfate More therapies…

    Learn about Your Condition

    Peritonitis Proteinuria Acute myocardial infarction Ventricular tachycardia Large cell lung cancer Langerhans' cell histiocytosis Tumour of ampulla of Vater Arteriosclerosis Herpes virus infection Autoimmune haemolytic anaemia Skin neoplasm excision K-ras gene mutation Penile squamous cell carcinoma Usher's syndrome Spinal cord injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Familial hypertriglyceridaemia

  • Study of ISIS 678354 for Patients with Familial Chylomicronemia Syndrome Previously Treated with Volanesorsen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Sweden

  • Study of ISIS 678354 for Patients with Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia France Greece Hungary +9

  • Study on the Effects of ISIS 678354 in Patients with Familial Chylomicronemia Syndrome (FCS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    France Italy The Netherlands Portugal Slovakia Spain +1

  • Study on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Austria Belgium Croatia France Ireland Poland +1

  • Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Bulgaria Czechia Denmark Finland France Germany +9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!